Professionnels de santé

Grand public

Presse
Ensemble, améliorons la qualité en santé

Home > Professionnels de santé > Actes - Médicaments - Dispositifs médicaux > Médicaments

Transparency Committee Opinion

LUCENTIS

Date 28 March 2007
Pharmaceutical
formulation

LUCENTIS 10 mg/ml, solution for injection
Box of 1 x 0.3 ml vials (CIP: 378 101-5)

ATC code
  1. S01LA04
Active ingredient

ranibizumab
Laboratory / Manufacturer NOVARTIS PHARMA S.A.S.
Reason for request Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals.

Documents

Tools

Contacts

Contact évaluation des médicaments

transparence@has-sante.fr


 

TAGS

Geriatrics - Eye diseases - Drug therapy
Haute Autorité de Santé - 2009